February was the biggest month on record for venture funding. And while the vast majority of that capital went to just three companies ' OpenAI, Anthropic and Waymo ' a whole host of under-the-radar startups also drew investor checks. Among those that most piqued our interest: A phlebotomy robot, a company that aims to revive precision manufacturing in the U.S. and Europe with a small-business franchise model, and a health beverage made from seaweed. Let's dive in. Vitestro was founded in 2017 and has raised more than $104 million to date, per Crunchbase. Its Series B investors include Sutter Health, Sonder Capital, Puma Venture Capital, Mayo Clinic and LabCorp Venture Fund, among others. Vitestro's device is designed to be installed in phlebotomy departments and combines imaging technology, AI and advanced robotics to identify suitable veins for a blood draw, guide needle insertion and collect blood samples, according to the company. 'Vitestro is redefining one of the largest and...
learn more
